none8siThe new drugs delamanid and bedaquiline are increasingly used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB). As evidence is lacking, the World Health Organization recommends their use under specific conditions in adults, delamanid only being recommended in children â¥6 years of age. No systematic review has yet evaluated the efficacy, safety and tolerability of the new drugs in children. A search of peer-reviewed, scientific evidence was performed, to evaluate the efficacy/effectiveness, safety, and tolerability of delamanid or bedaquiline-containing regimens in children with confirmed M/XDR-TB. We used PubMed and Embase to identify any relevant manuscripts in English until 31 December 2016,...
Introduction: In recent years, a pressing need to develop new, effective and safe drugs against tube...
It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each year. In...
It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each year. In...
The new drugs delamanid and bedaquiline are increasingly used to treat multidrug-resistant (MDR-) an...
none6Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are emerging p...
Multidrug-resistant (MDR) tuberculosis (TB) has been emerging at an alarming rate over the last few ...
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are emerging proble...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
none20It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each ye...
none20It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each ye...
none20It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each ye...
Introduction: In recent years, a pressing need to develop new, effective and safe drugs against tube...
It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each year. In...
It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each year. In...
The new drugs delamanid and bedaquiline are increasingly used to treat multidrug-resistant (MDR-) an...
none6Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are emerging p...
Multidrug-resistant (MDR) tuberculosis (TB) has been emerging at an alarming rate over the last few ...
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are emerging proble...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
none20It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each ye...
none20It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each ye...
none20It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each ye...
Introduction: In recent years, a pressing need to develop new, effective and safe drugs against tube...
It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each year. In...
It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each year. In...